Our top pick for
Tuniu Corporation is a travel services business based in the US. Tuniu Corporation shares (TOUR) are listed on the NASDAQ and all prices are listed in US Dollars. Tuniu Corporation employs 2,113 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$1.45|
|52-week range||$1.03 - $5.28|
|50-day moving average||$1.57|
|200-day moving average||$2.21|
|Wall St. target price||$2.82|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.27|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-5.84%|
|1 month (2021-09-21)||-1.36%|
|3 months (2021-07-21)||-31.60%|
|6 months (2021-04-21)||-50.68%|
|1 year (2020-10-21)||23.93%|
|2 years (2019-10-21)||-53.82%|
|3 years (2018-10-19)||6.45|
|5 years (2016-10-21)||9.82|
Valuing Tuniu Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tuniu Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tuniu Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6543. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tuniu Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$480.6 million|
|Gross profit TTM||$213.2 million|
|Return on assets TTM||-17.85%|
|Return on equity TTM||-56.04%|
|Market capitalisation||$185.3 million|
TTM: trailing 12 months
There are currently 246,744 Tuniu Corporation shares held short by investors – that's known as Tuniu Corporation's "short interest". This figure is 17.7% up from 209,615 last month.
There are a few different ways that this level of interest in shorting Tuniu Corporation shares can be evaluated.
Tuniu Corporation's "short interest ratio" (SIR) is the quantity of Tuniu Corporation shares currently shorted divided by the average quantity of Tuniu Corporation shares traded daily (recently around 141806.89655172). Tuniu Corporation's SIR currently stands at 1.74. In other words for every 100,000 Tuniu Corporation shares traded daily on the market, roughly 1740 shares are currently held short.
However Tuniu Corporation's short interest can also be evaluated against the total number of Tuniu Corporation shares, or, against the total number of tradable Tuniu Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tuniu Corporation's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Tuniu Corporation shares in existence, roughly 0 shares are currently held short) or 0.0058% of the tradable shares (for every 100,000 tradable Tuniu Corporation shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tuniu Corporation.
Find out more about how you can short Tuniu Corporation stock.
We're not expecting Tuniu Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Tuniu Corporation's shares have ranged in value from as little as $1.03 up to $5.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tuniu Corporation's is 2.4481. This would suggest that Tuniu Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tuniu Corporation operates as an online leisure travel company in China. The company offers various packaged tours, including organized and self-guided tours; and other travel-related services, such as tourist attraction tickets, visa application services, accommodation reservation, financial services, and hotel booking services, as well as air, train, and bus ticketing for leisure travelers. It also provides car rental and insurance services, as well as advertising services to tourism boards and bureaus. The company offers its products and services through various online and offline channels comprising tuniu. com website; mobile platform; a call center in Nanjing; a regional call center in Suqian; and other offline retail stores in China. Tuniu Corporation was founded in 2006 and is headquartered in Nanjing, the People's Republic of China. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.